Acuta Capital Partners, LLC Praxis Precision Medicines, Inc. Transaction History

Acuta Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.87 - $1.71 $204,450 - $401,850	235,000 Added 5.53%	4,485,000 $7.67 Million
Q2 2023 Aug 14, 2023	BUY	$0.83 - $1.18 $3.53 Million - $5.02 Million	4,250,000 New	4,250,000 $4.89 Million
Q2 2021 Aug 16, 2021	SELL	$18.28 - $33.05 $2.82 Million - $5.1 Million	-154,229 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$29.34 - $60.2 $2.31 Million - $4.73 Million	78,584 Added 103.89%	154,229 $5.05 Million
Q4 2020 Feb 16, 2021	BUY	$27.25 - $55.82 $2.06 Million - $4.22 Million	75,645 New	75,645 $4.16 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.